MorphoSys AG (NASDAQ:MOR)

8.48
Delayed Data
As of Jan 14
 -0.37 / -4.18%
Today’s Change
8.30
Today|||52-Week Range
30.75
-9.98%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.2B

Company Description

MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments. The Proprietary Development segment combines proprietary research and development of therapeutic compounds. The Partnered Discovery segment offers technologies to make human antibody-based therapeutics on behalf of partners in the pharmaceutical industry. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.

Contact Information

MorphoSys AG
Semmelweisstrasse 7
Planegg Bayern (bavaria) 82152
P:(498) 989-9270
Investor Relations:
498989927179

Employees

Shareholders

Other institutional1.47%
Mutual fund holders0.37%
Individual stakeholders--

Top Executives

Jean-Paul KressCEO & Chairman-Management Board
Sung H. LeeChief Financial Officer
Malte PetersChief Research & Development Officer
Armin WeidmannHead-Compliance & Quality Assurance
Charlotte LohmannSenior Vice President & General Counsel